McKesson Corporation (MCK)
Coverage summary
Aardvark Labs Capital Research has covered McKesson Corporation (MCK) since August 7, 2025. The company is in the Healthcare sector. This page lists 6 reports: 6 earnings recaps.
The latest is the Q2 FY27 Earnings Recap, published November 5, 2026. That report moved the rating from Hold to Underperform. The rating has changed 4 times since coverage began.
Translations: 5 in Chinese.
Rating history
All MCK reports
Recap: Q2 FY27
The Core Engine Finally Steps Up, and the Share Price Has Already Spent It
Recap: Q1 FY27
The Profit Case Strengthens, but the Valuation Recovery Has Arrived
Recap: Q4 FY26
The Revenue Miss Has Not Broken Earnings; the Lower Multiple Now Pays for the Risks
Recap: Q3 FY26
Specialty Delivers, but a 16.5% Rally Prices Away the Progress
Recap: Q2 FY26
The Distribution Margin Turned, the Raise Was Operational, and the Multiple Already Paid for Both
Recap: Q1 FY26
A Record Top Line, an In-Line Profit, and a Guidance Raise That Is All Accounting